Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Penumbra Inc Board/Management Information 2016

Nov 18, 2016

30612_rns_2016-11-18_033def0d-4a69-4539-9a13-6a9137a8d741.zip

Board/Management Information

Open in viewer

Opens in your device viewer

8-K 1 impt.htm 8-K html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd" Document created using Wdesk 1 Copyright 2016 Workiva Document

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 8-K


CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

November 15, 2016

Date of Report (Date of earliest event reported)


Penumbra, Inc.

(Exact name of registrant as specified in its charter)


Delaware 001-37557 05-0605598
(State or other jurisdiction of incorporation or organization) (Commission File No.) (I.R.S. employer identification number)

One Penumbra Place

Alameda, CA 94502

(Address of principal executive offices, including zip code)

(510) 748-3200

(Registrant’s telephone number, including area code)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(b) On November 15, 2016, Kevin Sullivan notified Penumbra, Inc. (the Company) of his decision to resign from the Board of Directors of the Company (the Board) and the Nominating and Corporate Governance Committee of the Board for personal health reasons, effective immediately. The decision by Mr. Sullivan was not a result of any disagreement with the Company or the Board.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

/s/ Sri Kosaraju
Sri Kosaraju
Chief Financial Officer and Head of Strategy